Financials in USD. Standardized financial statements.
A compact view of how bluebird bio, Inc. turns revenue into operating income and net income.
| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $83.81M | $29.50M | $3.60M | $3.66M | $250.73M | $44.67M | $54.58M | $35.43M | $6.16M | $14.08M |
| Revenue Growth? | +184.1% | +720.0% | -1.8% | -98.5% | +461.3% | -18.1% | +54.1% | +475.6% | -56.3% | 0.0% |
| Cost of Revenue? | $89.38M | $33.53M | $10.08M | $38.86M | $5.40M | $2.98M | $885,000 | $1.53M | $204.78M | $123.74M |
| Gross Profit? | -$5.57M | -$4.03M | -$6.48M | -$35.20M | $245.34M | $41.70M | $53.69M | $33.90M | -$198.62M | -$109.66M |
| Gross Margin? | -6.6% | -13.7% | -180.2% | -961.1% | +97.8% | +93.3% | +98.4% | +95.7% | -3227.0% | -778.9% |
| Operating Expenses? | $264.89M | $240.23M | $243.71M | $555.72M | $874.85M | $853.77M | $622.72M | $366.59M | $269.89M | $180.25M |
| Operating Income? | -$270.46M | -$244.26M | -$250.19M | -$590.91M | -$559.26M | -$812.08M | -$572.02M | -$332.17M | -$267.83M | -$169.04M |
| EBITDA? | -$156.82M | -$167.16M | -$215.56M | -$556.93M | -$553.63M | -$772.72M | -$551.87M | -$319.15M | -$254.47M | -$159.30M |
| Income Before Tax | -$240.65M | -$212.04M | -$230.22M | -$562.38M | -$560.37M | -$790.15M | -$555.44M | -$335.43M | -$264.12M | -$166.72M |
| Income Tax Expense | $70,000 | -$126,000 | $117,000 | $258,000 | $686,000 | -$545,000 | $187,000 | $210,000 | -$612,000 | $60,000 |
| Net Income? | -$240.72M | -$211.91M | -$230.34M | -$819.38M | -$618.70M | -$789.61M | -$555.63M | -$335.64M | -$263.51M | -$166.78M |
| EPS? | $-24.84 | $-2.97 | $-3.39 | $-8.16 | $-9.95 | $-14.31 | $-10.68 | $-7.71 | $-7.07 | $-4.81 |
| Diluted EPS? | $-24.84 | $-2.97 | $-3.39 | $-8.16 | $-9.95 | $-14.31 | $-10.68 | $-7.71 | $-7.07 | $-4.81 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality